Welcome to LookChem.com Sign In|Join Free
  • or
(S)-Boc-2-amino-3,3-dimethyl-pent-4-enoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

676629-90-6

Post Buying Request

676629-90-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

676629-90-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676629-90-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,6,2 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 676629-90:
(8*6)+(7*7)+(6*6)+(5*6)+(4*2)+(3*9)+(2*9)+(1*0)=216
216 % 10 = 6
So 676629-90-6 is a valid CAS Registry Number.

676629-90-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-3,3-dimethyl-N-Bocvinylglycine

1.2 Other means of identification

Product number -
Other names 2-(2,2-dimethyl-propionylamino)-3,3-dimethyl-pent-4-enoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:676629-90-6 SDS

676629-90-6Downstream Products

676629-90-6Relevant academic research and scientific papers

Process research and development and scale-up of a 4,4-difluoro-3,3- dimethylproline derivative

Rossi, Francesco,Corcella, Francesco,Caldarelli, Francesco Saverio,Heidempergher, Franco,Marchionni, Chiara,Auguadro, Miriam,Cattaneo, Marco,Ceriani, Lucio,Visentin, Giuseppina,Ventrella, Giambattista,Pinciroli, Vittorio,Ramella, Giuliano,Candiani, Ilaria,Bedeschi, Angelo,Tomasi, Attilio,Kline, Billie J.,Martinez, Carlos A.,Yazbeck, Daniel,Kucera, David J.

, p. 322 - 338 (2013/01/03)

The multikilogram production of the proline derivative 1, a key intermediate of a HIV protease inhibitor, required the design of a synthetic route able to be safely, effectively, and easily scaled up. Synthesis of the proline skeleton began with construction of racemic glycine derivative 4, via an ester enolate Claisen rearrangement of Boc-glycine 3-methyl-but-2-enyl ester (3) in the absence of a Lewis acid. After a classical resolution of 4 with (S)- phenylglycinol, (S)-4 was transformed into bromo-lactone 6b with NBS. The bromo-lactone was transformed to proline alcohol 8 via a base-promoted rearrangement involving lactone solvolysis. An NMR study suggested that a bicyclic lactone was initially formed, which subsequently opened by the methanol solvent to form 8. The requisite ketone for fluorination was prepared via oxidation of the enantiomerically pure 8, using NaClO and catalytic TEMPO. gem-Difluoro proline 1 was then prepared from the ketone via fluorination with Deoxo-Fluor. During this study it was discovered that SiO2 promoted fluorination by Deoxo-Fluor. This study allowed the production of 7.5 kg of 1 after 10 steps, in 4.5% molar yield and high purity (94-99% HPLC assay).

Efficient enzymatic process for the production of (2S)-4,4-difluoro-3,3- dimethyl-N-Boc-proline, a key intermediate in the synthesis of HIV protease inhibitors

Hu, Shanghui,Martinez, Carlos A.,Kline, Billie,Yazbeck, Daniel,Tao, Junhua,Kucera, David J.

, p. 650 - 654 (2012/12/22)

(2S)-4,4-Difluoro-3,3-dimethyl-N-Boc-proline (3) is a key intermediate for the synthesis of HIV protease inhibitors. Here, several approaches for the preparation of enantiopure 3 and its analogues are disclosed. Among these methods, one strategy relies on

METHODS FOR THE PREPARATION OF STEREOISOMERICALLY ENRICHED AMINES

-

Page/Page column 46-47, (2008/06/13)

The present invention relates to methods of preparing a stereoisomerically enriched compound of formula (I), wherein R6 is hydrogen, comprising treating a compound of formula (I), wherein R6 is chosen from C1-C10/sub

HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THE SAME AND THEIR PHARMACEUTICAL USES

-

Page/Page column 107, (2010/02/11)

This invention relates to a novel series of chemical compounds useful as Human immunodeficiency Virus (HIV) protease inhibitors and to the use of such compounds as antiviral agents. The invention further relates to pharmaceutical compositions containing s

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 676629-90-6